SOURCE: Syapse Inc

Syapse Inc

October 02, 2013 09:00 ET

Syapse Wins Strata Rx Startup Showcase

PALO ALTO, CA --(Marketwired - October 02, 2013) - Syapse, the leading precision medicine data platform, was declared the overall winner of the Strata Rx 2013 Startup Showcase competition. Founder and President Jonathan Hirsch presented the company's innovative cloud-based omics data platform based on novel semantic computing principles to enable the generation and use of omics profiles in diagnosing and treating patients.

Syapse was originally selected as one of 12 leading big data startups to demonstrate their cutting edge omics software to select Strata Rx attendees, including investors, entrepreneurs, and journalists. Among these 12 competitive startups, Syapse emerged as the leader with industry-changing technology that stood apart from the rest.

"We were excited to name Syapse as the Strata Rx Startup Showcase winner for their demonstrated efforts in bringing omics profiling to the clinic," said Colin Hill, organizing committee chair of Strata Rx and CEO of GNS Healthcare. "We were impressed with their vision, products, and market traction."

Upon receiving the honor, Founder and President Jonathan Hirsch gave a keynote address during the closing session in which he described the industry-leading work Syapse is doing in enabling clinical omics at diagnostic companies and hospitals. During his talk, Hirsch said, "Syapse is honored to be recognized for its contribution to integrating complex genomics and clinical data. We are excited to continue rolling out innovative products that allow physicians to integrate multi-omics data, clinical data, and clinician decision support at the point of care." Hirsch closed his presentation describing how Syapse is working with the Genetic Alliance on the Free the Data movement, an effort to crowdsource the interpretation of the cancer genome and provide the results in an open format for the medical community.

To view the Syapse keynote address, please visit:

Syapse is the leader in software for bringing omics into routine medical use. The Syapse team is currently developing a new product that will enable clinical omics labs to easily assemble and deliver interactive test reports to physicians. Syapse products work to make precision medicine a reality by connecting diagnostic companies, research institutions, medical centers, and payers to best diagnose and treat patients.

About Syapse

Syapse is disrupting healthcare by bringing omics into routine medical use. Built on a powerful cloud-based semantic data platform, Syapse applications enable the generation and use of omics profiles in diagnosing and treating patients at diagnostic companies, research institutions, medical centers, and payers. Led by an experienced, multidisciplinary team of entrepreneurs, software developers, and scientists, Syapse was founded at Stanford University and is backed by The Social+Capital Partnership. For more information, please see

About Strata Rx

Strata Rx focuses on using big data to drive innovations in analytics for healthcare -- including advances in personalized and predictive medicine; significant cost savings; and research that points to entirely new products and markets. Strata Rx is a unique forum bringing together the diverse communities driving innovations in big data analytics for healthcare. Healthcare leaders in areas such as drug development and medical devices can meet with payers, providers, mobile health pioneers, health IT practitioners, and patients, as well as developers, statisticians, analysts, and innovators. For more information, please see

Embedded Video Available:

Contact Information